Biosimilar Newsletter Archive

  1. 09.03.21 -- Pursuing Drug Delivery Excellence: Overcoming Challenges Of Biologics 9/3/2021

    09/03/21 Biosimilar Development Newsletter

  2. 09.02.21 -- Got Microorganisms? Determining Risk To Your Drug Product 9/2/2021
    09/02/21 Biosimilar Development Newsletter
  3. 08.29.21 -- Is The Legislative Intent Of The BPCIA In Danger? 8/29/2021
    08/29/21 Biosimilar Development Newsletter
  4. 08.26.21 -- Is The Legislative Intent Of The BPCIA In Danger? 8/26/2021
    08/26/21 Biosimilar Development Newsletter
  5. 08.23.21 -- Continuous And Process Intensification Strategies To Maximize Productivity And Efficiency 8/23/2021

    08/23/21 Biosimilar Development Newsletter

  6. 08.19.21 -- How To Select The Best Human Factors Method For Your Drug Device 8/19/2021
    08/19/21 Biosimilar Development Newsletter
  7. 08.12.21 -- Patent Transparency: The Revamped Purple Book 8/12/2021
    08/12/21 Biosimilar Development Newsletter
  8. 08.11.21 -- Enhancing Delivery For Oral Solids 8/11/2021

    08/11/21 Biosimilar Development Newsletter

  9. 08.11.21 -- New Podcast Alert! Cell and Gene: The Podcast 8/11/2021
    08/11/21 Biosimilar Development Newsletter
  10. 08.10.21 -- Start Your Automation Journey And Get To Market Faster - One Step At A Time 8/10/2021

    08/10/21 Biosimilar Development Newsletter